ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OSUR OraSure Technologies Inc

4.555
0.255 (5.93%)
Last Updated: 20:56:36
Delayed by 15 minutes
Share Name Share Symbol Market Type
OraSure Technologies Inc NASDAQ:OSUR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.255 5.93% 4.555 4.55 4.56 4.56 4.315 4.33 723,236 20:56:36

OraSure Technologies to Participate at the Sixth Annual JMP Securities Healthcare Conference

21/09/2011 11:00am

GlobeNewswire Inc.


OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more OraSure Technologies Charts.

OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the Sixth Annual JMP Securities Healthcare Conference in New York City at approximately 10:00am Eastern Time (7:00am Pacific Time) on Tuesday, September 27, 2011. The conference will be simultaneously webcast over the Internet.

Interested investors can access the live audio webcast of the discussion by going to OraSure Technologies' web site, www.orasure.com, and clicking on the Investor Information link. A replay of the audio webcast will be available until October 4, 2011, on OraSure Technologies' web site. Alternatively, you can access the live webcast of the presentation via the following link: http://wsw.com/webcast/jmp14/osur/.

About OraSure Technologies

OraSure Technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its innovative products include rapid tests for the detection of antibodies to HIV and HCV at the point of care and testing solutions for detecting various drugs of abuse. In addition, through its wholly-owned subsidiary, DNA Genotek Inc., the Company also is a leading provider of oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, and commercial and industrial entities. The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health.  

For more information on OraSure Technologies, please visit www.orasure.com. The OraSure Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6440

CONTACT: Ronald H. Spair
         Chief Financial Officer
         610-882-1820
         Investorinfo@orasure.com
         www.orasure.com

1 Year OraSure Technologies Chart

1 Year OraSure Technologies Chart

1 Month OraSure Technologies Chart

1 Month OraSure Technologies Chart